What is TLTFF's gross margin?

Theralase (TLTFF) has a gross margin of 52% and a net margin of -646%.

What is TLTFF's P/E ratio?

Track Theralase (TLTFF) P/E ratio, ROE, and valuation metrics over time.

Where can I see TLTFF's full financials?

See Theralase (TLTFF) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Theralase (TLTFF) Financials — Revenue, Earnings, Cash Flow

Also trades as: TLT.V (TSXV) · $vol 0M

$0.13

+0.00 (+0.28%)

Weekly Expected Move ±5.1%

$0 $0 $0 $0 $0

OTC · Healthcare · Medical - Devices · Tech Score Sell · Power 39 · $37.1M mcap · 237M float · 0.055% daily turnover · Short 57% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

📊 Key Metrics

TTM

$1M

Revenue

-24.8% YoY

$-4M

Net Income

+11.3% YoY

$-3M

Free Cash Flow

-2.4% YoY

52.1%

Gross Margin

-647.2%

Op. Margin

-646.5%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-93.5%

ROA-68.1%

ROIC-173.9%

Valuation

P/E-12.3

P/B7.3

EV/EBITDA0.0

Leverage

Debt/Equity0.02

Current Ratio5.48

Interest Cov.-62.5x

Quality Scores

Piotroski F4/9

Altman Z—

Beneish M-2.69